Genenta Science SPA
NASDAQ:SAEN
基本面分析
Genenta Science SPA 做什么
Genenta Science is a biotechnology company that develops gene therapy treatments for cancer. Its main idea is to take a patient’s blood-forming stem cells, modify them in the lab, and use them to deliver anti-tumor signals inside the body. The company’s lead work is centered on Temferon, a platform designed to help the immune system attack solid tumors from within the tumor environment.
- 总部
- 意大利 IT
- 员工人数
- 9
- 上市日期
- 2021年12月15日
利润瀑布图
Genenta Science SPA
继续研究 SAEN
已经对 Genenta Science 做出决定? 当 SAEN 达到您的买入价时,我们会发邮件通知您。 注册账户即可免费使用。